Bruton tyrosine kinase (BTK) which is only slightly downstream of the receptor itself activates the cell survival pathway NfK-B and MAP kinases, its inhibition leads to apoptosis of CLL cells [49]. This evidence concerns the gene NFKB1 and B-cell chronic lymphocytic leukemia.